Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 6, 2001, Pages 375-386

  Lahm, Harald ^a   André, Sabine ^b   Hoeflich, Andreas ^a   Fischer, Jürgen R ^c   Sordat, Bernard ^d   Kaltner, Herbert ^b   Wolf, Eckhard ^a   Gabius, Hans Joachim ^b  

^a Gene Center   (Germany)

^b Faculty of Veterinary Medicine   (Germany)

^c Thoraxklinik Heidelberg ^*  (Germany)

^d SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Apoptosis; Galectin; Human neoplasia; Lectin; Tumor diagnosis; Tumor growth control

Indexed keywords

GALECTIN; GALECTIN 3; LECTIN; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CONTROLLED STUDY; CYTOFLUOROMETRY; DIAGNOSTIC VALUE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA FINGERPRINTING; WESTERN BLOTTING;

ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA; COLONIC NEOPLASMS; FEMALE; FLOW CYTOMETRY; GALECTIN 1; GALECTIN 3; GALECTINS; HEMAGGLUTININS; HUMANS; LECTINS; LUNG NEOPLASMS; NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0035017215     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320000207     Document Type: Article

References (76)

1. Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A (1997) Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57: 5272-5276
2. Amado M, Almeida R, Schwientek T, Clausen H (1999) Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta 1473: 35-53
3. André S, Kojima S, Yamazaki N, Fink C, Kaltner H, Kayser K, Gabius H-J (1999) Galectins-1 and -3 and their ligands in tumor biology. J Cancer Res Clin Oncol 125: 461-474
4. Bepler G, Rotsch M, Jacques G, Haeder M, Heymanns J, Hartogh G, Kiefer P, Havemann K (1988) Peptides and growth factors in small cell lung cancer: production, binding sites and growth effects. J Cancer Res Clin Oncol 114: 235-244
5. Bepler G, Bading H, Heimann B, Kiefer P, Havemann K, Moelling K (1989) Expression of p64 c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Oncogene 4: 45-50
6. Bernerd F, Sarasin A, Magnaldo T (1999) Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci USA 96: 11329-11334
7. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771
8. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A (1998) Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin-3. Gastroenterology 115: 287-296
9. Brockhausen I, Schutzbach J, Kuhns W (1998) Glycoproteins and their relationship to human diseases. Acta Anat 161: 36-78
10. Cajot JF, Sordat I, Silvestre T, Sordat B (1997) Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells. Cancer Res 57: 2593-2597
11. Carrel S, Sordat B, Merenda C (1976) Establishment of a cell line (Co-115) from a human colon carcinoma transplanted into nude mice. Cancer Res 36: 3978-3984
12. Cherayil BJ, Chaitovitz S, Wong C, Pillai S (1990) Molecular cloning of a human lectin specific for galactose. Proc Natl Acad Sci USA 87: 7324-7328
13. Chiarotti L, Salvatore P, Benvenuto G, Bruni CB (1999) Control of galectin gene expression. Biochimie 81: 381-388
14. Cooper DNW, Barondes SH (1999) God must love galectins; He made so many of them. Glycobiology 9: 979-984
15. Danielsen EM, van Deurs B (1997) Galectin-4 and small intestinal brush border enzymes form clusters. Mol Biol Cell 8: 2241-2251
16. Delorge S, Saussez S, Pelc D, Devroede B, Marchant H, Burchert M, Zeng F-Y, Danguy A, Salmon I, Gabius H-J, Kiss R, Hassid S (2000) Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 122: 834-841
17. Deveney CW, Rand-Luby L, Rutten MJ, Luttropp CA, Fowler WM, Land J, Meichsner CL, Farahmand M, Sheppard BC, Crass RA, Deveney KE (1996) Establishment of human colonic epithelial cells in long-term culture. J Surg Res 64: 161-169
18. Ellerhorst J, Nguyen T, Cooper DNW, Lotan D, Lotan R (1999a) Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype. Int J Oncol 14: 217-224
19. Ellerhorst J, Nguyen T, Cooper DNW, Estrov Y, Lotan D, Lotan R (1999b) Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1. Int J Oncol 14: 225-232
20. François C, van Velthoven R, De Lathouwer O, Moreno C, Peltier A, Kaltner H, Salmon I, Gabius H-J, Danguy A, Decaestecker C, Kiss R (1999) Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. Am J Clin Pathol 112: 194-203
21. Furukawa K, Sato T (1999) β-1,4-Galactosylation of N-glycans is a complex process. Biochim Biophys Acta 1473: 54-66
22. Gabius H-J (1989) Endogene Lektine in Tumoren und ihre mögliche Bedeutung für Diagnose und Therapie von Krebserkrankungen. Onkologie 12: 175-181
23. Gabius H-J (1997a) Animal lectins. Eur J Biochem 243: 543-576
24. Gabius H-J (1997b) Concepts of tumor lectinology. Cancer Invest 15: 454-464
25. Gabius H-J (2000) Biological information transfer beyond the genetic code: the sugar code. Naturwissenschaften 87: 108-121
26. Gabius H-J (2001) Glycohistochemistry: the why and how of detection and localization of endogenous lectins. Anat Histol Embryol (in press)
27. Gabius H-J, Gabius S (1990) Tumorlektinologie: Status und Perspektiven klinischer Anwendung. Naturwissenschaften 77: 505-514
28. Gabius H-J, Engelhardt R, Rehm S, Cramer F (1984) Biochemical characterization of endogenous carbohydrate-binding proteins from spontaneous murine rhabdomyosarcoma, mammary adenocarcinoma and ovarian teratoma. J Natl Cancer Inst 73: 1349-1357
29. Gabius H-J, Brehler R, Schauer A, Cramer F (1986a) Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas. Virchows Arch 52: 107-115
30. Gabius H-J, Engelhardt R, Rehm S, Barondes SH, Cramer F (1986b) Presence and relative distribution of three endogenous β-galactoside-specific lectins in different tumor types of rat. Cancer J 1: 19-22
31. Gitt MA, Massa SM, Leffler H, Barondes SH (1992) Isolation and expression of a gene encoding L-14-II, a new human soluble lactose-binding lectin. J Biol Chem 267: 10601-10606
32. Hadari YR, Eisenstein M, Zakut R, Zick Y (1997) Galectin-8: on the road from structure to function. Trends Glycosci Glycotechnol 9: 103-112
33. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, Zick Y (2000) Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci 113: 2385-2397
34. Hakomori S-I (1998) Cancer-associated glycosphingolipid antigens: their structure, organization and function. Acta Anat 161: 79-90
35. Hirabayashi J (ed) (1997) Recent topics on galectins. Trends Glycosci Glycotechnol 9: 1-180
36. Hirabayashi J, Ayaki H, Soma G-I, Kasai K-I (1988) Cloning and nucleotide sequence of a full-length cDNA for human 14 kDa β-galactoside-binding lectin. Biochim Biophys Acta 1008: 85-91
37. Huflejt ME, Jordan ET, Gitt MA, Barondes SH, Leffler H (1997) Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells. Galectin-4 is localized at sites of cell adhesion. J Biol Chem 272: 14294-14303
38. Hughes RC (1993) Mac-2: a versatile galactose-binding protein of mammalian tissues. Glycobiology 4: 5-12
39. Itzkowitz SH (1997) Galectins: multipurpose carbohydrate-binding proteins implicated in tumor biology. Gastroenterology 113: 2003-2005
40. Kaltner H, Stierstorfer B (1998) Animal lectins as cell adhesion molecules. Acta Anat 161: 162-179
41. Kayser K, Bovin NV, Korchagina EY, Zeilinger C, Zeng F-Y, Gabius H-J (1994) Correlation of expression of binding sites for synthetic blood group A-, B-, and H-trisaccharides and for sarcolectin with survival of patients with bronchial carcinoma. Eur J Cancer 30 A: 653-657
42. Kayser K, Biechele U, Dienemann H, André S, Bovin NV, Gabius H-J (1998) Pulmonary metastases of breast carcinomas: ligandohistochemical, nuclear, and structural analysis of primary and metastatic tumors with emphasis on period of occurrence of metastases and survival. J Surg Oncol 69: 137-146
43. Kim H-RC, Lin H-M, Biliran H, Raz A (1999) Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res 59: 4148-4154
44. Lahm H, Hoeflich A, André S, Sordat B, Kaltner H, Wolf E, Gabius H-J (2000) Gene expression of galectin-9/ecalectin, a potent eosinophil chemoattractant, and/or the insertional isoform in human colorectal carcinoma cell lines and detection of frame-shift mutations for protein sequence truncations in the second functional lectin domain. Int J Oncol 17: 519-524
45. Laine RA (1997) The information-storing potential of the sugar code. In: Gabius H-J, Gabius S (eds) Glycosciences: status and perspectives. Chapman & Hall, London Weinheim, pp 1-14
46. Le Marer N, Hughes RC (1996) Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells. J Cell Physiol 168: 51-58
47. Lu J, Pei H, Kaeck M, Thompson HJ (1997) Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog 20: 204-215
48. Madsen P, Rasmussen HH, Flint T, Gromov P, Kruse TA, Honoré B, Vorum H, Cells JE (1995) Cloning, expression, and chromosome mapping of human galectin-7. J Biol Chem 270: 5823-5829
49. Matarrese P, Fusco O, Tinari N, Natoli C, Liu F-T, Semeraro ML, Malorni W, Iacobelli S (2000a) Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer 85: 545-554
50. Matarrese P, Tinari N, Semeraro ML, Natoli C, Iacobelli S, Malorni W (2000b) Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 473: 311-315
51. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hirashima M (1998) Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273: 16976-16984
52. Matsushita N, Nishi N, Seki M, Matsumoto R, Kuwabara I, Liu F-T, Hata Y, Nakamura T, Hirashima M (2000) Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J Biol Chem 275: 8355-8360
53. Nangia-Makker P, Thomson E, Hogan C, Ochieng J, Raz A (1995) Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line. Int J Oncol 7: 1079-1087
54. Nangia-Makker P, Akahani S, Bresalier S, Raz A (2000) The role of galectin-3 in tumor metastasis. In: Caron M, Sève A-P (eds) Lectins and pathology. Harwood Academic, Amsterdam, pp 67-77
55. Ohannesian DW, Lotan D, Thomas P, Jessup JM, Fukuda M, Gabius H-J, Lotan R (1995) Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells. Cancer Res 55: 2191-2199
56. Ohannesian DW, Lotan R (1997) Galectins in tumor cells. In: Gabius H-J, Gabius S (eds) Glycosciences: status and perspectives. Chapman & Hall, London Weinheim, pp 459-469
57. Perillo NL, Marcus ME, Baum LG (1998) Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 76: 402-412
58. Plzák J, Smetana K, Betka J, Kodet R, Kaltner H, Gabius H-J (2000) Endogenous lectins (galectins-1 and -3) as probes to detect differentiation-dependent alterations in human squamous cell carcinomas of oropharynx and larynx. Int J Mol Med 5: 369-372
59. Polyak K, Xia Y, Zweler JL, Kinzler KW, Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 300-305
60. Rabinovich GA (1999) Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ 6: 711-721
61. Raz A, Meromsky L, Carmi P, Karakash R, Lotan D, Lotan R (1984) Monoclonal antibodies to endogenous galactose-specific tumor cell lectins. EMBO J 3: 2979-2983
62. Rechreche H, Mallo GV, Montalto G, Dagorn J-C, Iovanna JL (1997) Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer. Eur J Biochem 248: 225-230
63. Reuter G, Gabius H-J (1999) Eukaryotic glycosylation: whim of nature or multipurpose tool? Cell Mol Life Sci 55: 368-422
64. Rüdiger H, Siebert H-C, Solís D, Jiménez-Barbero J, Romero A, von der Lieth C-W, Diaz-Mauriño T, Gabius H-J (2000) Medicinal chemistry based on the sugar code: fundamentals of lectinology and experimental strategies with lectins as targets. Curr Med Chem 7: 389-416
65. Scanlan MJ, Chen Y-T, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci Ö, Sahin U, Pfreundschuh M, Old LJ (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76: 652-658
66. Schwarz G, Remmelink M, Decaestecker C, Gielen I, Budel V, Burchert M, Darro F, Danguy A, Gabius H-J, Salmon I, Kiss R (1999) Galectin fingerprinting in tumor diagnosis. Differential expression of galectin-3 and galectin-3-binding sites, but not of galectin-1, in benign versus malignant uterine smooth muscle tumors. Am J Clin Pathol 111: 623-631
67. Solís D, Romero A, Kaltner H, Gabius H-J, Díaz-Mauriño T (1996) Different architecture of the combining site of the two chicken galectins revealed by chemical mapping studies with synthetic ligand derivatives. J Biol Chem 271: 12744-12748
68. Sparrow CP, Leffler H, Barondes SH (1987) Multiple soluble β-galactoside-binding lectins from human lung. J Biol Chem 262: 7383-7390
69. Su Z-Z, Lin J, Shen R, Fisher PE, Goldstein NI, Fisher PB (1996) Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. Proc Natl Acad Sci USA 93: 7252-7257
70. Teichberg VI, Silman I, Beitsch DD, Resheff G (1975) A β-D-galactoside-binding protein from electric organ tissue of Electrophorus electricus. Proc Natl Acad Sci USA 72: 1383-1387
71. Türeci Ö, Schmitt H, Fädle N, Pfreundschuh M, Sahin U (1997) Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272: 6416-6422
72. Villalobo A, Gabius H-J (1998) Signaling pathways for transduction of the initial message of the glycocode into cellular responses. Acta Anat 161: 110-129
73. Warfield PR, Nangia-Makker P, Raz A, Ochieng J (1997) Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis 17: 101-112
74. Yang RY, Hsu DK, Liu F-T (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93: 6737-6742
75. Yilmaz A, Gaide A-C, Sordat B, Borbenyi Z, Lahm H, Imam A, Schreyer M, Odartchenko N (1993) Malignant progression of SV40-immortalised human milk epithelial cells. Br J Cancer 68: 868-873
76. Zanetta J-P (1997) Lectins and carbohydrates in animal cell adhesion and control of cell proliferation. In: Gabius H-J, Gabius S (eds) Glycosciences: status and perspectives. Chapman & Hall, London Weinheim, pp 439-458